Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

17.15
+0.92005.67%
Post-market: 17.150.00000.00%19:30 EDT
Volume:218.39K
Turnover:3.65M
Market Cap:637.02M
PE:-2.31
High:17.19
Open:16.39
Low:16.03
Close:16.23
52wk High:27.41
52wk Low:8.72
Shares:37.14M
Float Shares:15.95M
Volume Ratio:1.33
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4105
EPS(LYR):-12.8150
ROE:-160.75%
ROA:-69.15%
PB:8.78
PE(LYR):-1.34

Loading ...

Stifel Nicolaus Reaffirms Their Buy Rating on Crescent Biopharma (CBIO)

TIPRANKS
·
Jun 23

Crescent Biopharma grants inducement stock options for 23,550 shares at $17.57 each

Reuters
·
Jun 12

Crescent Biopharma shareholders elect two Class II directors at annual meeting

Reuters
·
Jun 03

Crescent Biopharma to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
Jun 03

Crescent Biopharma Shares Fall After HC Wainwright Downgrade

MT Newswires Live
·
Jun 02

Analysts Are Bullish on These Healthcare Stocks: Crescent Biopharma (CBIO), IQVIA Holdings (IQV)

TIPRANKS
·
Jun 01

Crescent Biopharma Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Jun 01

Crescent Biopharma downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
Jun 01

Crescent Biopharma grants inducement stock options for 16,950 shares at $21.47 each

Reuters
·
May 30

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB)

TIPRANKS
·
May 26

Crescent Biopharma presents ASCEND Phase 1/2 CR-001 trial-in-progress at ASCO 2026

Reuters
·
May 22

Crescent Biopharma Announces Trial in Progress Presentation for Ascend Study of Cr-001, a Pd-1 X Vegf Bispecific Antibody, at Upcoming American Society of Clinical Oncology (Asco) 2026 Annual Meeting

THOMSON REUTERS
·
May 22

Crescent Biopharma grants inducement stock options for 129,075 shares at $18.52

Reuters
·
May 13

Rainbows and Unicorns: Crescent Biopharma, Inc. (NASDAQ:CBIO) Analysts Just Became A Lot More Optimistic

Simply Wall St.
·
May 07

Crescent Biopharma Down Over 16%, On Pace for Largest Percent Decrease Since July 2024 -- Data Talk

Dow Jones
·
May 01

Stifel Nicolaus Keeps Their Buy Rating on Crescent Biopharma (CBIO)

TIPRANKS
·
May 01

Crescent Biopharma Q1 EPS $(0.70) Beats $(0.98) Estimate, Sales $1.039M Beat $357.143K Estimate

Benzinga Earnings
·
Apr 30

Crescent Biopharma grants inducement stock options for 12,525 shares at $25.7 each

Reuters
·
Apr 25

Crescent Biopharma announces annual shareholder meeting notice

Reuters
·
Apr 22

Crescent Biopharma (CBIO) Gets a Buy from Piper Sandler

TIPRANKS
·
Apr 10